Table 3. Incidence and Risk of COVID-19 by Unvaccinated or Partially Vaccinated, Fully Vaccinated, and Boosted Populations.
Vaccine doses | COVID-19 incidence (95% CI) | COVID-19 hospitalization (95% CI) | COVID-19 severe disease (95% CI) | ||||||
---|---|---|---|---|---|---|---|---|---|
Active treatment | Cancer survivors | Controls | Active treatment | Cancer survivors | Controls | Active treatment | Cancer survivors | Controls | |
Delta wave | |||||||||
0 or 1 dose | 0.64 (0.50-0.82) | 0.92 (0.75-1.13) | 0.28 (0.26-0.30) | 1.57 (1.18-2.10) | 2.80 (2.16-3.62) | 0.99 (0.88-1.11) | 3.37 (1.92-5.91) | 9.37 (6.34-13.84) | 2.51 (2.12-2.96) |
2 doses | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
3 doses | 0.37 (0.29-0.48) | 0.34 (0.29-0.40) | 0.26 (0.25-0.28) | 0.24 (0.15-0.38) | 0.23 (0.16-0.33) | 0.14 (0.11-0.17) | 0.14 (0.03-0.59) | 0.13 (0.05-0.33) | 0.07 (0.05-0.12) |
Omicron wave | |||||||||
0 or 1 dose | 0.71 (0.59-0.87) | 0.73 (0.63-0.85) | 0.40 (0.37-0.44) | NAa | NAa | NAa | 1.85 (0.99-3.47) | 1.56 (1.02-2.39) | 0.82 (0.62-1.08) |
2 doses | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
3 doses | 0.91 (0.86-0.97) | 0.91 (0.86-0.96) | 0.91 (0.88-0.93) | 0.45 (0.40-0.52) | 0.27 (0.24-0.32) | 0.29 (0.27-0.32) | 0.29 (0.20-0.42) | 0.19 (0.14-0.26) | 0.21 (0.18-0.25) |
4 doses | 0.78 (0.70-0.88) | 0.80 (0.74-0.87) | 0.85 (0.81-0.88) | 0.24 (0.18-0.33) | 0.15 (0.12-0.19) | 0.21 (0.18-0.25) | 0.13 (0.06-0.31) | 0.10 (0.06-0.17) | 0.10 (0.07-0.15) |
Incidence ratio ratios for COVID-19 hospitalization not shown because interpretation was confounded by mandatory inpatient treatment of unvaccinated or partially vaccinated patients with confirmed COVID-19 infection.